Марей М.В.

In rat model perspective of two novel trends of preventing and treatment of acute post-ischemic renal failure (ARF) was investigated, in particular application of two drugs referred to novel class of antioxidants, which are selectively accumulated in mitochondria of renal tubular epithelium, which conditionally denoted as SkQ1 and SkQR, as well as administration of cultured human bone marrow-derived mesenchymal stem cells (BM-MSC) and cultured fetal renal cells (CRC).